Metabolic Diseases

Metabolic·MeSH: Metabolic Diseases

7 drugs in development·6 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
mipomersen	TG THERAPEUTICS, INC. (TGTX)

Phase 2(2)

Drug	Company
akcea-angptl3-lrx	AKCEA THERAPEUTICS, INC. (AKCA)
kds2010	SCILEX HOLDING CO (SCLX)

Phase 1(1)

Drug	Company
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)

Preclinical(3)

Drug	Company
ADX-743	Aldeyra Therapeutics, Inc. (ALDX)
undisclosed cardiometabolic program 1	Korro Bio, Inc. (KRRO)
undisclosed cardiometabolic program 2	Korro Bio, Inc. (KRRO)

BioSniper tracks 7 drugs in development for Metabolic Diseases across 6 companies.

There are 6 clinical trials targeting Metabolic Diseases tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.